AusPAR: nirmatrelvir/ritonavir

Australian Public Assessment Report

AusPAR

AusPAR: nirmatrelvir/ritonavir [PDF, 3.8 MB]

AusPAR: nirmatrelvir/ritonavir [Word, 10.81 MB]

Attachment: Product information for nirmatrelvir/ritonavir [PDF, 395.4 KB]

Attachment: Product information for nirmatrelvir/ritonavir [Word, 229.66 KB]

Device/Product Name

Paxlovid

Active ingredients

nirmatrelvir/ritonavir

AusPAR Date

24 January 2022

Published

25 January 2022

Submission Number

PM-2021-04880-1-2

Submission Type

New chemical entity

Decision

Approved for provisional registration